| 201 |
Synthesis and biological evaluation of cystobactamid 507: A bacterial topoisomerase inhibitor from Cystobacter sp. |
2015 |
| 202 |
Synthesis and investigation of antihypertensive activity using anaesthetized normotensive nonhuman primates of some 2-aryl-4-(substituted) pyrimido[1,2-a] benzimidazoles |
2015 |
| 203 |
Synthesis, anti-inflammatory and molecular docking of some new 1,2,4-triazolobenzimidazol-3-yl acetone thiosemicarbazone cyclized derivatives as PLA-2 inhibitors |
2015 |
| 204 |
Synthesis, anti-inflammatory and molecular docking of some new 1,2,4-triazolobenzimidazol-3-yl acetone thiosemicarbazone cyclized derivatives as PLA-2 inhibitors |
2015 |
| 205 |
Synthesis, anti-inflammatory and molecular docking of some new 1,2,4-triazolobenzimidazol-3-yl acetone thiosemicarbazone cyclized derivatives as PLA-2 inhibitors |
2015 |
| 206 |
Synthesis, anti-inflammatory and molecular docking of some new 1,2,4-triazolobenzimidazol-3-yl acetone thiosemicarbazone cyclized derivatives as PLA-2 inhibitors |
2015 |
| 207 |
Design and Synthesis of New (SecinH3) Derivatives as Potential Cytohesin Inhibitors |
2014 |
| 208 |
Design and synthesis of new pyrido[2,3-d]pyrimidine-1,4-dione derivatives as anti-inflammatory agents |
2014 |
| 209 |
Design and Synthesis of Some New Purine-dione Derivatives of Potential Anti- inflammatory Activity |
2014 |
| 210 |
Discovery of New HER2/EGFR Dual Kinase Inhibitors Based on the Anilinoquinazoline Scaffold as Potential Anti-Cancer Agents |
2014 |
